Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice
CJC-1295 was originally made to treat diseases, but has been discovered to have performance enhancing effects that appeal to athletes
A 2024 meta analysis of clinical trials concluded that 2.4mg semaglutide produces sustained weight loss that is well tolerated and safe. That said, there is a recognized semaglutide weight loss plateau
In 2021, a research team led by Professor Peter Arthur Calabresi, Director of the Multiple Sclerosis Center at Johns Hopkins University School of Medicine, published findings in the international journal Neurotherapeutics (Impact Factor: 6.9) indicating that NLY01 significantly slowed the progression of MS in animal models by reducing neuroinflammation and protecting nerve cells
However, these medications do not immediately affect water weight, which can sometimes lead to confusion when the scale does not move as expected
Studies using continuous glucose monitoring and metabolic chambers show that patients experience increased cravings, reduced feelings of fullness, and shifts in food preference toward high-calorie options
